Cargando…

Imaging noradrenergic influence on amyloid pathology in mouse models of Alzheimer’s disease

INTRODUCTION: Molecular imaging aims towards the non-invasive characterization of disease-specific molecular alterations in the living organism in vivo. In that, molecular imaging opens a new dimension in our understanding of disease pathogenesis, as it allows the non-invasive determination of the d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Winkeler, A., Waerzeggers, Y., Klose, A., Monfared, P., Thomas, A. V., Schubert, M., Heneka, M. T., Jacobs, A. H.
Formato:	Texto
Lenguaje:	English
Publicado:	Springer-Verlag 2008
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2755760/ https://www.ncbi.nlm.nih.gov/pubmed/18219484 http://dx.doi.org/10.1007/s00259-007-0710-0

Ejemplares similares

Noradrenergic dysfunction in Alzheimer's disease
por: Gannon, Mary, et al.
Publicado: (2015)

Switching on the Lights for Gene Therapy
por: Winkeler, Alexandra, et al.
Publicado: (2007)

Noradrenergic Dysfunction in Alzheimer's and Parkinson's Diseases—An Overview of Imaging Studies
por: Peterson, Andrew C., et al.
Publicado: (2018)

Noradrenergic therapies for apathy in Alzheimer’s disease?
por: Husain, Masud
Publicado: (2023)

New approaches for the quantification and targeting of noradrenergic dysfunction in Alzheimer's disease
por: David, Michael, et al.
Publicado: (2022)

Pathological Increases in Neuronal Hyperactivity in Selective Cholinergic and Noradrenergic Pathways May Limit the Efficacy of Amyloid-β-Based Interventions in Mild Cognitive Impairment and Alzheimer’s Disease
por: Pomara, Nunzio, et al.
Publicado: (2018)

Widespread Reduced Density of Noradrenergic Locus Coeruleus Axons in the App Knock-In Mouse Model of Amyloid-β Amyloidosis
por: Sakakibara, Yasufumi, et al.
Publicado: (2021)

Towards Astroglia-based Noradrenergic Hypothesis of Alzheimer’s Disease
por: Leanza, Giampiero, et al.
Publicado: (2022)

Magnetic resonance imaging of noradrenergic neurons
por: Watanabe, Takashi, et al.
Publicado: (2019)

Immunotherapy alleviates amyloid-associated synaptic pathology in an Alzheimer’s disease mouse model
por: Dorostkar, Mario M., et al.
Publicado: (2014)

Noradrenergic Signaling in Astrocytes Influences Mammalian Sleep Homeostasis
por: Ingiosi, Ashley M., et al.
Publicado: (2022)

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
por: David, Michael C B, et al.
Publicado: (2022)

Degenerative alterations in noradrenergic neurons of the locus coeruleus in Alzheimer's disease
por: Liu, Lihua, et al.
Publicado: (2013)

Characterization of a Novel Mouse Model of Alzheimer’s Disease—Amyloid Pathology and Unique β-Amyloid Oligomer Profile
por: Liu, Peng, et al.
Publicado: (2015)

Melanocortin receptor activation alleviates amyloid pathology and glial reactivity in an Alzheimer’s disease transgenic mouse model
por: Lau, Jackie K. Y., et al.
Publicado: (2021)

Alzheimer’s disease amyloid-β pathology in the lens of the eye
por: Moncaster, Juliet A., et al.
Publicado: (2022)

Early-Onset and Robust Amyloid Pathology in a New Homozygous Mouse Model of Alzheimer's Disease
por: Willuweit, Antje, et al.
Publicado: (2009)

Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
por: Betts, Matthew J, et al.
Publicado: (2019)

The influence of the noradrenergic system on optimal control of neural plasticity
por: Silvetti, Massimo, et al.
Publicado: (2013)

Reduction of β-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease
por: Paris, Daniel, et al.
Publicado: (2010)

Amyloid beta and diabetic pathology cooperatively stimulate cytokine expression in an Alzheimer’s mouse model
por: Sankar, Sitara B., et al.
Publicado: (2020)

Astrocyte reactivity influences amyloid-β effects on tau pathology in preclinical Alzheimer’s disease
por: Bellaver, Bruna, et al.
Publicado: (2023)

Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow
por: Li, Hongmei, et al.
Publicado: (2014)

Plasma Amyloid as Prescreener for the Earliest Alzheimer Pathological Changes
por: Verberk, Inge M. W., et al.
Publicado: (2018)

In vivo Image of Cerebral Amyloid Angiopathy in an Alzheimer's Disease Mouse Model
por: Kim, Jinho, et al.
Publicado: (2015)

Impact of Donepezil on Brain Glucose Metabolism Assessed Using [(18)F]2-Fluoro-2-deoxy-D-Glucose Positron Emission Tomography Imaging in a Mouse Model of Alzheimer’s Disease Induced by Intracerebroventricular Injection of Amyloid-Beta Peptide
por: Hugon, Gaëlle, et al.
Publicado: (2022)

Microglial-associated responses to comorbid amyloid pathology and hyperhomocysteinemia in an aged knock-in mouse model of Alzheimer’s disease
por: Braun, David J., et al.
Publicado: (2020)

Secretagogin expression in the vertebrate brainstem with focus on the noradrenergic system and implications for Alzheimer’s disease
por: Zahola, Péter, et al.
Publicado: (2019)

Alzheimer's disease: An evolving understanding of noradrenergic involvement and the promising future of electroceutical therapies
por: Slater, Cody, et al.
Publicado: (2021)

Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
por: Thal, Dietmar Rudolf, et al.
Publicado: (2019)

Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer’s disease
por: Puli, Lakshman, et al.
Publicado: (2012)

Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer’s amyloid pathology
por: Stepanchuk, Anastasiia A., et al.
Publicado: (2022)

Antibody-based PET imaging of amyloid beta in mouse models of Alzheimer's disease
por: Sehlin, Dag, et al.
Publicado: (2016)

Altered synaptic structure in the hippocampus in a mouse model of Alzheimer’s disease with soluble amyloid-β oligomers and no plaque pathology
por: Price, Katherine A, et al.
Publicado: (2014)

Correction to: Different aspects of Alzheimer’s disease-related amyloid β-peptide pathology and their relationship to amyloid positron emission tomography imaging and dementia
por: Thal, Dietmar Rudolf, et al.
Publicado: (2020)

The Dichotomy of Alzheimer’s Disease Pathology: Amyloid-β and Tau
por: Ashford, J. Wesson
Publicado: (2019)

In the blood: biomarkers for amyloid pathology and neurodegeneration in Alzheimer’s disease
por: Toombs, Jamie, et al.
Publicado: (2020)

Cardiometabolic Modification of Amyloid Beta in Alzheimer’s Disease Pathology
por: Hefner, Marleigh, et al.
Publicado: (2021)

An amyloid beta vaccine that safely drives immunity to a key pathological species in Alzheimer’s disease: pyroglutamate amyloid beta
por: Vukicevic, M., et al.
Publicado: (2022)

Soluble amyloid-beta isoforms predict downstream Alzheimer’s disease pathology
por: Povala, Guilherme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_66131e0dqbkquhdefoooo6a6ni